Brickell Historical Valuation

BBIDelisted Stock  USD 1.79  0.34  23.45%   
Some fundamental drivers such as market cap or Brickell Biotech enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze Brickell Biotech valuation indicators such as Average Assets of 37.6 M or Average Equity of 31.1 M to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of Brickell Biotech's future value. Financial Statement Analysis is much more than just reviewing and breaking down Brickell Biotech prevalent accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Brickell Biotech is a good buy for the upcoming year.
Continue to Trending Equities.
  

About Brickell Valuation Data Analysis

Valuation is the financial process of determining what Brickell Biotech is worth. Brickell Biotech valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. Brickell Biotech valuation ratios help investors to determine whether Brickell Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Brickell with respect to the benefits of owning Brickell Biotech security.

Brickell Biotech Valuation Data Chart

Brickell valuation ratios help to determine how cheap or expensive it is, compared to its peers or based on some benchmark measure of value for a given date. A typical valuation ratio shows the difference between the cost of Brickell equity instrument and the benefits of owning shares of Brickell Biotech.
Brickell Biotech Enterprise Value is decreasing as compared to previous years. The preceding year's Enterprise Value was reported at 4.47 Million. The current Market Capitalization is estimated to increase to about 24.3 M, while Net Income Per Employee is projected to decrease to (1.9 M).

Average Assets

Average asset value for the period used in calculation of Return on Average Equity and Return on Average Assets; derived from Total Assets.

Enterprise Value

Enterprise Value (or EV) is usually referred to as Brickell Biotech theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Brickell Biotech debt, but would also pocket its cash. Enterprise Value is more accurate representation of Brickell Biotech value than its market capitalization because it takes into account all of Brickell Biotech existing debt. Enterprise value is a measure of the value of a business as a whole; calculated as Market Capitalization plus Total Debt USD minus Cash and Equivalents USD.

Market Capitalization

Market capitalization (or market cap) is the total value of the shares outstanding of Brickell Biotech. It is equal to Brickell Biotech current share price times the number of Brickell Biotech outstanding shares. Represents the product of [SharesBas]; [Price] and [ShareFactor].
Most indicators from Brickell Biotech's valuation accounts are interrelated and interconnected. However, analyzing valuation accounts indicators one by one will only give a small insight into Brickell Biotech current financial condition. On the other hand, looking into the entire matrix of valuation accounts indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Continue to Trending Equities.Brickell Biotech Enterprise Value is decreasing as compared to previous years. The preceding year's Enterprise Value was reported at 4.47 Million. The current Market Capitalization is estimated to increase to about 24.3 M, while Net Income Per Employee is projected to decrease to (1.9 M).
 2020 2021 2022 2023 (projected)
Enterprise Value22.04 M4.97 M4.47 M4.59 M
Average Equity17.91 M24.09 M21.68 M31.07 M

Brickell Biotech valuation accounts Correlations

Brickell Biotech Account Relationship Matchups

Brickell Biotech valuation accounts Accounts

201820192020202120222023 (projected)
Net Income Per Employee(122.58 K)(175.13 K)(541.8 K)(1.59 M)(1.83 M)(1.88 M)
Revenue Per Employee198.51 K186.74 K54.07 K527.8 K475.02 K512.52 K
Average Assets45.63 M34.66 M25.13 M30.46 M27.41 M37.61 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA(8.07 M)(12.36 M)(16.15 M)(21.75 M)(19.58 M)(21.12 M)
Earnings Before Interest Taxes and Depreciation Amortization USD(8.1 M)(21.75 M)(20.9 M)(39.38 M)(35.44 M)(36.38 M)
Earnings before Tax(9.24 M)(23.88 M)(20.91 M)(39.47 M)(35.53 M)(36.46 M)
Average Equity23.07 M27.82 M17.91 M24.09 M21.68 M31.07 M
Enterprise Value13.45 M4.59 M22.04 M4.97 M4.47 M4.59 M
Free Cash Flow3.96 M(35.99 M)(20.06 M)(36.18 M)(32.57 M)(33.42 M)
Invested Capital(15.21 M)488 K(2.4 M)(1.98 M)(1.78 M)(1.83 M)
Invested Capital Average28.85 M20.09 M(1.32 M)(2.55 M)(2.3 M)(2.36 M)
Market Capitalization25.74 M11.72 M41.77 M26.33 M23.7 M24.32 M
Tangible Asset Value8.31 M18.14 M33.63 M29.72 M26.75 M35.13 M
Working Capital(11.82 M)7.47 M27.18 M24.79 M22.31 M27.66 M
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Brickell Biotech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Brickell Biotech's short interest history, or implied volatility extrapolated from Brickell Biotech options trading.

Pair Trading with Brickell Biotech

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Brickell Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brickell Biotech will appreciate offsetting losses from the drop in the long position's value.

Moving against Brickell Biotech

-0.8TATT Inc Earnings Call This WeekPairCorr
-0.61DDDupont De Nemours Earnings Call TomorrowPairCorr
The ability to find closely correlated positions to Brickell Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Brickell Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Brickell Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Brickell Biotech to buy it.
The correlation of Brickell Biotech is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Brickell Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Brickell Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Brickell Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Trending Equities. Note that the Brickell Biotech information on this page should be used as a complementary analysis to other Brickell Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Consideration for investing in Brickell Stock

If you are still planning to invest in Brickell Biotech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Brickell Biotech's history and understand the potential risks before investing.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
CEO Directory
Screen CEOs from public companies around the world
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data